{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:37:24Z","timestamp":1790087844198,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijid.2025.108198","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T09:49:21Z","timestamp":1762768161000},"page":"108198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical risk factors, antimicrobial therapy, and virulence-associated mortality in patients with extensively drug-resistant or pan-drug-resistant (XDR\/PDR) Pseudomonas aeruginosa pulmonary infections"],"prefix":"10.1016","volume":"162","author":[{"given":"Yixin","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijid.2025.108198_bib0001","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jiph.2023.12.012","article-title":"Whole genome sequencing of resistance and virulence genes in multi-drug resistant Pseudomonas aeruginosa","volume":"17","author":"Almaghrabi","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijid.2025.108198_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5365\/wpsar.2020.11.1.006","article-title":"Genomic surveillance of Pseudomonas aeruginosa in the Philippines, 2013-2014","volume":"12","author":"Chilam","year":"2021","journal-title":"Western Pac Surveill Response J"},{"key":"10.1016\/j.ijid.2025.108198_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41670","article-title":"Molecular characterization and genome sequencing of selected highly resistant clinical isolates of Pseudomonas aeruginosa and its association with the clustered regularly interspaced palindromic repeat\/Cas system","volume":"11","author":"Owaid","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.ijid.2025.108198_bib0004","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/infdis\/jiw299","article-title":"Host and pathogen biomarkers for severe Pseudomonas aeruginosa infections","volume":"215","author":"Juan","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2025.108198_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01759-19","article-title":"Predictors of mortality in bloodstream infections caused by Pseudomonas aeruginosa and impact of antimicrobial resistance and bacterial virulence","volume":"64","author":"Recio","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2025.108198_bib0006","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","article-title":"The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update","volume":"81","author":"Reynolds","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ijid.2025.108198_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics10010042","article-title":"It\u2019s not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa","volume":"10","author":"Behzadi","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijid.2025.108198_bib0008","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ijms24021269","article-title":"Comparison of virulence-factor-encoding genes and genotype distribution amongst clinical Pseudomonas aeruginosa strains","volume":"24","author":"Bogiel","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijid.2025.108198_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126719","article-title":"Type 3 secretion system of Pseudomonas aeruginosa","volume":"246","author":"Horna","year":"2021","journal-title":"Microbiol Res"},{"issue":"9","key":"10.1016\/j.ijid.2025.108198_bib0010","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.drudis.2021.02.026","article-title":"Pseudomonas aeruginosa elastase (LasB) as a therapeutic target","volume":"26","author":"Everett","year":"2021","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.ijid.2025.108198_bib0011","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1462-2920.2012.02732.x","article-title":"Identification of reciprocal adhesion genes in pathogenic and non-pathogenic Pseudomonas","volume":"15","author":"Duque","year":"2013","journal-title":"Environ Microbiol"},{"issue":"22","key":"10.1016\/j.ijid.2025.108198_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228671","article-title":"Pseudomonas aeruginosa biofilms","volume":"21","author":"Thi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijid.2025.108198_bib0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5114\/ceji.2018.74869","article-title":"Age-related variations in the in vitro bactericidal activity of human sera against Pseudomonas aeruginosa","volume":"43","author":"Khan","year":"2018","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.ijid.2025.108198_bib0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jip.2013.10.006","article-title":"Diverse effects of Galleria mellonella infection with entomopathogenic and clinical strains of Pseudomonas aeruginosa","volume":"115","author":"Andrejko","year":"2014","journal-title":"J Invertebr Pathol"},{"key":"10.1016\/j.ijid.2025.108198_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102544","article-title":"The influence of efflux pump, outer membrane permeability and \u03b2-lactamase production on the resistance profile of multi, extensively and pandrug resistant Klebsiella pneumoniae","volume":"17","author":"Hussein","year":"2024","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijid.2025.108198_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04261-22","article-title":"Epidemiological and genetic characteristics of clinical carbapenem-resistant Pseudomonas aeruginosa strains in Guangdong Province, China","volume":"11","author":"Zhao","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijid.2025.108198_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/IDR.S346313","article-title":"Epidemiology, molecular characteristics, and virulence factors of carbapenem-resistant Pseudomonas aeruginosa isolated from patients with urinary tract infections","volume":"15","author":"Park","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2025.108198_bib0018","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jgar.2024.04.002","article-title":"Genome analysis of extensively drug-resistant Pseudomonas aeruginosa ST1971 from a patient in China hospitalized for severe pneumonia","volume":"38","author":"Jiang","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijid.2025.108198_bib0019","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jiph.2023.12.012","article-title":"Whole genome sequencing of resistance and virulence genes in multi-drug resistant Pseudomonas aeruginosa","volume":"17","author":"Almaghrabi","year":"2024","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijid.2025.108198_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2018.04.3437","article-title":"Prognostic factors for 7-day and 30-day mortality during gram-negative bacteremia episodes in cancer and hematopoietic stem cell transplant patients","volume":"73","author":"Herrera","year":"2018","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108198_bib0021","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019 \u2013 results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijid.2025.108198_bib0022","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1099\/jmm.0.009142-0","article-title":"Pseudomonas aeruginosa \u2013 a phenomenon of bacterial resistance","volume":"58","author":"Strateva","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijid.2025.108198_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0315490","article-title":"Investigation of carbapenemase-encoding genes in Burkholderia cepacia and Aeromonas sobria isolates from nosocomial infections in Iraqi patients","volume":"20","author":"Al-Ouqaili","year":"2025","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijid.2025.108198_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2025.108198_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2025.108198_bib0026","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jac\/dkl063","article-title":"Levofloxacin\/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs","volume":"57","author":"Lister","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2025.108198_bib0027","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","article-title":"Pseudomonas aeruginosa: all roads lead to resistance","volume":"19","author":"Breidenstein","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijid.2025.108198_bib0028","first-page":"201","article-title":"Association of biofilm formation with multi drug resistance in clinical isolates of Pseudomonas aeruginosa","volume":"19","author":"Abdulhaq","year":"2020","journal-title":"EXCLI J"},{"key":"10.1016\/j.ijid.2025.108198_bib0029","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s40001-022-00752-6","article-title":"Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration","volume":"27","author":"Kothari","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ijid.2025.108198_bib0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/pathogens11030300","article-title":"Pathogenesis of the Pseudomonas aeruginosa biofilm: a review","volume":"11","author":"Tuon","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ijid.2025.108198_bib0031","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1074\/jbc.M116.760074","article-title":"Cooperative substrate-cofactor interactions and membrane localization of the bacterial phospholipase A2 (PLA2) enzyme, ExoU","volume":"292","author":"Tessmer","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijid.2025.108198_bib0032","doi-asserted-by":"crossref","first-page":"42936","DOI":"10.1074\/jbc.M406493200","article-title":"ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through rho GTPase guanine nucleotide disassociation inhibitor","volume":"279","author":"Sun","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijid.2025.108198_bib0033","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1128\/IAI.69.9.5318-5328.2001","article-title":"Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function","volume":"69","author":"Fraylick","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2025.108198_bib0034","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.hlife.2023.02.001","article-title":"Emergence of hypervirulent Pseudomonas aeruginosa pathotypically armed with co-expressed T3SS effectors ExoS and ExoU","volume":"1","author":"Song","year":"2023","journal-title":"hLife"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:33:27Z","timestamp":1766406807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225004205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"alternative-id":["S1201971225004205"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108198","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical risk factors, antimicrobial therapy, and virulence-associated mortality in patients with extensively drug-resistant or pan-drug-resistant (XDR\/PDR) Pseudomonas aeruginosa pulmonary infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108198"}}